An insight into pleiotropic regulators Agr and Sar: Molecular probes paving the new way for antivirulent therapy

Future Microbiology

Volumn 8, Issue 10, 2013, Pages 1339-1353

  Arya, Rekha ^a   Princy, S Adline ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

agr locus; biofilm; community acquired MRSA; pathogenesis; sar locus; Staphylococcus aureus

Indexed keywords

AGR PROTEIN; AUTOINDUCING PEPTIDE INHIBITOR; BACTERIAL PROTEIN; CIPROFLOXACIN; DAPTOMYCIN; LINEZOLID; PEPTIDE; PEPTOMER; RNAIII INHIBITING PEPTIDE; SAR PROTEIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; WINGED HELIX TRANSCRIPTION FACTOR;

BACTERIAL VIRULENCE; BIOFILM; GENE LOCUS; MOLECULAR PROBE; NONHUMAN; PARALOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUORUM SENSING; REGULATOR GENE; REVIEW; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; VIRULENCE FACTORS;

EID: 84884993949     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.92     Document Type: Review

References (92)

1. Kobayashi SD, Musser JM, Deleo FR. Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureus. MBio 3(4), e00170-e00212 (2012).
2. Gardete S, Kim C, Hartmann BM et al. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog. 8(2), e1002505 (2012).
3. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus Infection. Clin. Infect. Dis. 46(Suppl. 5), S350-S359 (2008).
4. Ruiz ME, Guerrero IC, Tuazon CU. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin. Infect. Dis. 35(8), 1018-1020 (2002).
5. Rudkin JK, Edwards AM, Bowden MG et al. Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system. J. Infect. Dis. 205(5), 798-806 (2012).
6. Beenken KE, Mrak LN, Griffin LM et al. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS ONE 5(5), e10790 (2010).
7. Traber KE, Lee E, Benson S et al. Agr function in clinical Staphylococcus aureus isolates. Microbiology 154(Pt 8), 2265-2274 (2008).
8. Dunman PM, Murphy E, Haney S et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183(24), 7341-7353 (2001).
9. Wright JS 3rd, Lyon GJ, George EA, Muir TW, Novick RP. Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing. Proc. Natl Acad. Sci. USA 101(46), 16168-16173 (2004).
10. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48(6), 1429-1449 (2003).
11. Jarraud S, Lyon GJ, Figueiredo AM et al. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 82(22), 6517-6522 (2000).
12. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 276(5321), 2027-2030 (1997).
13. Saenz HL, Augsburger V, Vuong C, Jack RW, Götz F, Otto M. Inducible expression and cellular location of AgrB, a protein involved in the maturation of the staphylococcal quorum-sensing pheromone. Arch. Microbiol. 174(6), 452-455 (2000).
14. Zhang L, Ji G. Identification of a staphylococcal AgrB Segment(s) responsible for group-specific processing of AgrD by gene swapping. J. Bacteriol. 186(20), 6706-6713 (2004).
15. Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, Hurlburt BK. Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J. Bacteriol. 186(22), 7549-7555 (2004).
16. Cheung AL, Ying P. Regulation of a-and b-hemolysins by the sar locus of Staphylococcus aureus. J. Bacteriol. 176(3), 580-585 (1994).
17. Ziebandt AK, Becher D, Ohlsen K, Hacker J, Hecker M, Engelmann S. The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 4(10), 3034-3047 (2004).
18. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect. Immun. 79(5), 1927-1935 (2011).
19. Tsompanidou E, Sibbald MJ, Chlebowicz MA et al. Requirement of the agr locus for colony spreading of Staphylococcus aureus. J. Bacteriol. 193(5), 1267-1272 (2011).
20. Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J. Bacteriol. 189(6), 2553-2557 (2007).
21. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4(4), e1000052 (2008).
22. Geisinger E, George EA, Chen J, Muir TW, Novick RP. Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor. J. Biol. Chem. 283(14), 8930-8938 (2008).
23. Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect. Immun. 61(9), 3879-3885 (1993).
24. Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect. Immun. 68(3), 1048-1053 (2000).
25. Fujimoto DF, Higginbotham RH, Maleki SJ, Segall AM, Smeltzer MS, Hurlburt BK. Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase-mediated excision/ recombination. Mol. Microbiol. 74(6), 1445-1458 (2009).
26. Cheung AL, Nishina K, Manna AC. SarA of Staphylococcus aureus binds to the sarA promoter to regulate gene expression. J. Bacteriol. 190(6), 2239-2243 (2008).
27. Cheung AL, Manna AC. Role of the distal sarA promoters in SarA expression in Staphylococcus aureus. Infect. Immun. 73(7), 4391-4394 (2005).
28. Roberts C, Anderson KL, Murphy E et al. Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives. J. Bacteriol. 188(7), 2593-2603 (2006).
29. Sterba KM, Mackintosh SG, Blevins JS, Hurlburt BK, Smeltzer MS. Characterization of Staphylococcus aureus SarA binding sites. J. Bacteriol. 185(15), 4410-4417 (2003).
30. Rechtin TM, Gillaspy AF, Schumacher MA, Brennan RG, Smeltzer MS, Hurlburt BK. Characterization of the SarA virulence gene regulator of Staphylococcus aureus. Mol. Microbiol. 33(2), 307-316 (1999).
31. Karlsson A, Arvidson S. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect. Immun. 70(8), 4239-4246 (2002).
32. Lamichhane-Khadka R, Cantore SA, Riordan JT et al. SarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus. Int. J. Antimicrob. Agents 34(2), 136-141 (2009).
33. Manna AC, Ingavale SS, Maloney M, van Wamel W, Cheung AL. Identification of SarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus. J. Bacteriol. 186(16), 5267-5280 (2004).
34. Cheung AL, Schmidt K, Bateman B, Manna AC. SarS, a SarA homolog repressible by agr, is an activator of protein A synthesis in Staphylococcus aureus. Infect. Immun. 69(4), 2448-2455 (2001).
35. Morrison JM, Anderson KL, Beenken KE, Smeltzer MS, Dunman PM. The staphylococcal accessory regulator, SarA, is an RNA-binding protein that modulates the mRNA turnover properties of late-exponential and stationary phase Staphylococcus aureus cells. Front. Cell. Inf. Microbiol. 2, 26 (2012).
36. Zielinska AK, Beenken KE, Joo HS et al. Defining the strain-dependent impact of the staphylococcal accessory regulator (sarA) on the a-toxin phenotype of Staphylococcus aureus. J. Bacteriol. 193(12), 2948-2958 (2011).
37. Mrak LN, Zielinska AK, Beenken KE et al. saeRS and sarA act synergistically to repress protease production and promote biofilm formation in Staphylococcus aureus. PLoS ONE 7(6), e38453 (2012).
38. Bronner S, Stoessel P, Gravet A, Monteil H, Prévost G. Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR. Appl. Environ. Microbiol. 66(9), 3931-3938 (2000).
39. Dumitrescu O, Choudhury P, Boisset S et al. b-lactams interfering with PBP1 induce panton-valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob. Agents Chemother. 55(7), 3261-3271 (2011).
40. Ballal A, Manna AC. Expression of the sarA family of genes in different strains of Staphylococcus aureus. Microbiology 155(Pt 7), 2342-2352 (2009).
41. Trotonda MP, Tamber S, Memmi G, Cheung AL. MgrA represses biofilm formation in Staphylococcus aureus. Infect. Immun. 76(12), 5645-5654 (2008).
42. Trotonda MP, Xiong YQ, Memmi G, Bayer AS, Cheung AL. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J. Infect. Dis. 199(2), 209-218 (2009).
43. Cheung AL, Zhang G. Are the structures of SarA and SarR similar? Trends Microbiol. 9(12), 570-573 (2001).
44. Manna A, Cheung AL. Characterization of sarR, a modulator of sar expression in Staphylococcus aureus. Infect. Immun. 69(2), 885-896 (2001).
45. Oscarsson J, Harlos C, Arvidson S. Regulatory role of proteins binding to the spa (protein A) and sarS (staphylococcal accessory regulator) promoter regions in Staphylococcus aureus NTCC 8325-4. Int. J. Med. Microbiol. 295(4), 253-266 (2005).
46. Manna AC, Ray B. Regulation and characterization of rot transcription in Staphylococcus aureus. Microbiology 153(Pt 5), 1538-1545 (2007).
47. Said-Salim B, Dunman PM, McAleese FM et al. Global regulation of Staphylococcus aureus genes by Rot. J. Bacteriol. 185(2), 610-619 (2003).
48. Schmidt KA, Manna AC, Cheung AL. SarT influences sarS expression in Staphylococcus aureus. Infect. Immun. 71(9), 5139-5148 (2003).
49. Manna AC, Cheung AL. SarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infect. Immun. 71(1), 343-353 (2003).
50. Liu Y, Manna AC, Pan CH et al. Structural and function analyses of the global regulatory protein SarA from Staphylococcus aureus. Proc. Natl Acad. Sci. USA 103(7), 2392-2397 (2006).
51. Chien Y, Manna AC, Cheung AL. SarA level is a determinant of agr activation in Staphylococcus aureus. Mol. Microbiol. 30(5), 991-1001 (1998).
52. Luong TT, Newell SW, Lee CY. Mgr, a novel global regulator in Staphylococcus aureus. J. Bacteriol. 185(13), 3703-3710 (2003).
53. Gorske BC, Blackwell HE. Interception of quorum sensing in Staphylococcus aureus: a new niche for peptidomimetics. Org. Biomol. Chem. 4(8), 1441-1445 (2006).
54. Qui R, Pei W, Zhang L, Lin J, Ji G. Identification of the putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage of AgrD to generate autoinducing peptide. J. Biol. Chem. 280(17), 16695-16704 (2005).
55. Harraghy N, Kerdudou S, Herrmann M. Quorum-sensing systems in staphylococci as therapeutic targets. Anal. Bioanal. Chem. 387(2), 437-444 (2007).
56. Balaban N, Cirioni O, Giacometti A et al. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob. Agents Chemother. 51(6), 2226-2229 (2007).
57. Balaban N, Goldkorn T, Gov Y et al. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J. Biol. Chem. 276(4), 2658-2667 (2001).
58. Fowler SA, Stacy DM, Blackwell HE. Design and synthesis of macrocyclic peptomers as mimics of a quorum sensing signal from Staphylococcus aureus. Org. Lett. 10(12), 2329-2332 (2008).
59. MDowell P, Affas Z, Reynolds C et al. Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol. Microbiol. 41(2), 503-512 (2001).
60. Arya R, Kannan RV, Shrivastava S, Princy SA. Studies on the effect of amino acids to curb the pathogenesis of multidrug resistant Staphylococcus aureus. Asian J. Chem. 23(10), 4295-4298 (2011).
61. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect. Dis. Clin. North Am. 16(2), 297-318 (2002).
62. Shopsin B, Drlica-Wagner A, Mathema B, Adhikari RP, Kreiswirth BN, Novick RP. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J. Infect. Dis. 198(8), 1171-1174 (2008).
63. Fowler VG Jr, Sakoulas G, McIntyre LM et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190(6), 1140-1149 (2004).
64. Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190(8), 1498-1505 (2004).
65. Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 55(6), 2655-2661 (2011).
66. Park J, Jagasia R, Kaufmann GF et al. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem. Biol. 14(10), 1119-1127 (2007).
67. Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus Reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl Acad. Sci. USA 108(8), 3360-3365 (2011).
68. Cheung AL, Bayer MG, Heinrichs JH. Sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus. J. Bacteriol. 179(12), 3963-3971 (1997).
69. Chien Y, Manna AC, Cheung AL. SarA level is a determinant of agr activation in Staphylococcus aureus. Mol. Microbiol. 30(5), 991-1001 (1998).
70. Arya R, Princy SA. Computational approach to design small molecule inhibitors and identify SarA as a potential therapeutic candidate. Med. Chem. Res. 22(4), 1856-1865 (2013).
71. Schmidt KA, Donegan NP, Kwan WA Jr, Cheung A. Influences of sigmaB and agr on expression of staphylococcal enterotoxin B (seb) in Staphylococcus aureus. Can. J Microbiol. 50(5), 351-360 (2004).
72. Regassa LB, Couch JL, Betley MJ. Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose. Infect. Immun. 59(3), 955-962 (1991).
73. Tseng CW, Zhang S, Stewart GC. Accessory gene regulator control of staphyloccoccal enterotoxin D gene expression. J. Bacteriol. 186(6), 1793-1801 (2004).
74. Cheung AL, Koomey JM, Butler CA, Projan SJ, Fischetti VA. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl Acad. Sci. USA 89(14), 6462-6466 (1992).
75. Seidl K, Chen L, Bayer AS, Hady WA, Kreiswirth BN, Xiong YQ. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 55(12), 5631-5639 (2011).
76. Dajcs JJ, Austin MS, Sloop GD et al. Corneal pathogenesis of Staphylococcus aureus strain newman. Invest. Ophthalmol. Vis. Sci. 43(4), 1109-1115 (2002).
77. Kato F, Kadomoto N, Iwamoto Y, Bunai K, Komatsuzawa H, Sugai M. Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus. Infect. Immun. 79(4), 1660-1670 (2011).
78. Attia AS, Benson MA, Stauff DL, Torres VJ, Skaar EP. Membrane damage elicits an immunomodulatory program in Staphylococcus aureus. PLoS Pathog. 6(3), e1000802 (2010).
79. Chamberlain NR, Imanoel B. Genetic regulation of fatty acid modifying enzyme from Staphylococcus aureus. J. Med. Microbiol. 44(2), 125-129 (1996).
80. Hübscher J, Jansen A, Kotte O et al. Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus. BMC Genomics 8, 307 (2007).
81. Gustafsson E, Oscarsson J. Maximal transcription of aur (aureolysin) and sspA (serine protease) in Staphylococcus aureus requires staphylococcal accessory regulator R (sarR) activity. FEMS Microbiol. Lett. 284(2), 158-164 (2008).
82. Makris G, Wright JD, Ingham E, Holland KT. The hyaluronate lyase of Staphylococcus aureus -a virulence factor? Microbiology 150(Pt 6), 2005-2013 (2004).
83. Blevins JS, Beenken KE, Elasri MO, Hurlburt BK, Smeltzer MS. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect. Immun. 70(2), 470-480 (2002).
84. Daugherty S, Low MG. Cloning, expression, and mutagenesis of phosphatidylinositol-specific phospholipase C from Staphylococcus aureus: a potential staphylococcal virulence factor. Infect. Immun. 61(12), 5078-5089 (1993).
85. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: Staphylokinase. Int. J. Biochem. Cell. Biol. 38(4), 504-509 (2006).
86. Andrey DO, Renzoni A, Monod A, Lew DP, Cheung AL, Kelley WL. Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA. J. Bacteriol. 192(22), 6077-6085 (2010).
87. Wirtz C, Witte W, Wolz C, Goerke C. Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background. Microbiology. 155(Pt 11), 3491-3499 (2009).
88. Pohlmann-Dietze P, Ulrich M, Kiser KB et al. Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect. Immun. 68(9), 4865-4871 (2000).
89. Van Wamel W, Xiong YQ, Bayer AS, Yeaman MR, Nast CC, Cheung AL. Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb Pathog. 33(2), 73-79 (2002).
90. Luong T, Sau S, Gomez M, Lee JC, Lee CY. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect. Immun. 70(2), 444-450 (2002).
91. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 40(1), 1-9 (2004).
92. Xiong YQ, Bayer AS, Yeaman MR, Van Wamel W, Manna AC, Cheung AL. Impacts of sarA and agr in Staphylococcus aureus strain Newman on fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect. Immun. 72(3), 1832-1836 (2004).